SuperworthErnexa Therapeutics EPS ERNA
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$18.60
- Latest quarter, Q2 FY26
- −$3.40
- Fiscal year 2025
- −$81.20
Ernexa Therapeutics' earnings per share was −$18.60 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$3.40.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$81.20 | n/a |
| FY2024 | −$2744.00 | n/a |
| FY2023 | −$1530.00 | n/a |
| FY2022 | −$3146.25 | n/a |
| FY2021 | −$20733.75 | n/a |
| FY2020 | −$11325.00 | n/a |
| FY2019 | −$10650.00 | n/a |
| FY2018 | −$1650.00 | n/a |
| FY2017 | −$6450.00 | n/a |
| FY2016 | −$23400.00 | n/a |
| FY2015 | −$55500.00 | n/a |
| FY2014 | −$45000.00 | n/a |
| FY2013 | −$7500.00 | n/a |
| FY2012 | −$15000.00 | n/a |
| FY2011 | −$45000.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$3.40 | n/a | −$18.60 | |
| Q1 FY26 | −$6.95 | n/a | −$30.39 | |
| Q4 FY25 | −$4.50 | n/a | −$81.20 | |
| Q3 FY25 | −$3.75 | n/a | −$133.45 | |
| Q2 FY25 | −$15.19 | n/a | −$1972.20 | |
| Q1 FY25 | −$57.76 | n/a | −$2340.51 | |
| Q4 FY24 | −$56.75 | n/a | −$2744.00 | |
| Q3 FY24 | −$1842.50 | n/a | −$3114.75 | |
| Q2 FY24 | −$383.50 | n/a | −$1658.50 | |
| Q1 FY24 | −$461.25 | n/a | −$1593.75 | |
| Q4 FY23 | −$427.50 | n/a | −$1530.00 | |
| Q3 FY23 | −$386.25 | n/a | −$1567.50 |
Against its peers
Companies in Healthcare nearest Ernexa Therapeutics' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ERNAErnexa Therapeutics | −$18.60 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Ernexa Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.